monly used in bronchoscopic surgery, and most interventional bronchoscopists 1 2 consider it as Background -A number of treatments, including Nd-YAG laser therapy, brachy-the standard device. Other types of laser (argon dye, krypton ion, helium-cadmium laser) are therapy, cryotherapy, electrocautery, and photodynamic therapy, can re-open the used in association with chromogens for photodynamic therapy 3 and for early detection of obstructed bronchial lumen in patients with inoperable obstructive bronchial bronchial cancer. 4 In contrast, electrocautery 5 is not widely used in bronchology. tumours. None of these is considered to be a "gold standard".
is not widely used in bronchology. tumours. None of these is considered to be a "gold standard".
We have used two alternative techniquesradiosurgery and cryotherapy -to treat our Methods -The results of a retrospective study of 98 patients treated by radio-patients. Radiosurgery is a new technology which has not previously been used in bronchfrequency tissue ablation and subsequent cryotherapy between January 1994 and ology. Radiofrequency tissue ablation is a technique for making thermal lesions around the tip June 1995 are reported. The patients were divided in two groups according to whether of an electrode as a result of tissue coagulation caused by resistive heating. The electrode can they were treated either after (group 1, n= 50) or before (group 2, n=48) radiotherapy be applied directly onto superficial structures surgically, endoscopically, laparoscopically, or and/or chemotherapy. Bronchoscopic follow up was performed. The intervention via a catheter; the latter technique has become a well established treatment for many sympwas considered successful if the lumen was opened by >80% and partially successful tomatic cardiac arrhythmias. 6 Thermal methods such as the use of radiofrequency if it was opened by >50%. Results -In group 1 treatment was suc-induced tissue coagulation were used in early clinical trials for treating osteoid osteomas, 7 cessful in 60%, partially successful in 32%, and unsuccessful in 8%. The median sur-hepatic tumours, 8 and lung tissue. 9 When attached to the appropriate generator, radiovival time was five months from the time of bronchoscopic surgery. In group 2 frequency energy is emitted from the exposed uninsulated portion of the electrode. This entreatment was successful in 66%, partially successful in 21.5%, and unsuccessful in ergy translates into ion agitation which is converted into heat and induces cellular death via 12.5%, with a median survival time of 14 months from the time of bronchoscopic coagulation necrosis. In theory, radiofrequency can be used to sculpt precisely the volume of treatment. Forty patients (24 in group 1 and 16 in group 2) received a Dumon stent. necrosis to match the extent of the tumour.
Cryosurgery is safe and inexpensive and acts Conclusions -Radiofrequency bronchoscopic surgery with cryotherapy appears by immediate protein coagulation and cellular sensitise the tumour to chemotherapy/radiotherapy in non pre-treated patients (group 1). of an extrathoracic malignancy. The patients Antibiotic coverage was routinely performed were divided into two groups according to the after the intervention. One week after cryotime of radiotherapy/chemotherapy; 50 patients therapy bronchial debridement was performed were treated after receiving radiotherapy/ using a rigid bronchoscope and a stent was chemotherapy (group 1) and 48 patients were inserted when indicated using a Herrel-Dumon treated before radiotherapy/chemotherapy (Efer, France) bronchoscopic introducer. Stent (group 2). Details of the patients are given in insertion was restricted to cases where rapid table 1.
re-stenosis was likely -for example, cases of extrinsic compression. In the other cases we avoided or delayed stent insertion, particularly  if we thought that further re-opening of the Bronchoscopy was performed via a rigid bron-bronchial lumen could be expected from the choscope (Storz, Germany or Efer, France) chemotherapy/radiotherapy. using neuroleptoanalgesia (diazepam 5-10 mg
The patients were discharged on the same + fentanyl 3-5 g/kg+propofol 1 mg/kg) to evening whenever possible. Repeat bronmaintain spontaneous ventilation. Blood pres-choscopy to assess for re-stenosis was persure, electrocardiographic parameters, heart formed at one week and then two monthly rate, and oxygen saturation were monitored.
thereafter. The radiofrequency generator used operates at 1750 kHz, maximum power 99W, in continuous, single, repeated pulse and superpulse emission and with the functions of cut, coagulation, cut/coagulation, and superficial coagulation. A Huzly thermic loop 5 and/or coagulator probe (both Storz, Germany; fig 1) Radiofrequency resection group.bmj.com on September 29, 2017 -Published by http://thorax.bmj.com/ Downloaded from by the tumour regrowth and it was replaced with a longer one after further radiofrequency treatment. In another case in group 2 the stent migrated from the right main bronchus toward the tracheal lumen during radiotherapy, probably because of further bronchial reopening, and it was replaced with a larger one.
Discussion
The main purpose of interventional bronchoscopy in malignancy is to restore the patency of the airways. This treatment may improve respiratory function, reduce the likelihood of obstructive pneumonia or empyema and, in cases of severe tracheal stenosis, may be life saving. While the treatment may be only symptomatic in patients who have already failed with radiotherapy/chemotherapy, it may allow others to receive this treatment which would otherwise have been contraindicated by severe respiratory failure and/or pleuropulmonary infection. From our experience of bronchoscopic  Bronchoscopic follow up assess for re-stenosis cryosurgery 11 in more than 600 patients treated since 1976 we consider it to be a safe procedure was performed at one week and then two monthly thereafter; the intervention was con-for the treatment of tumours infiltrating the bronchial wall as perforations do not occur sidered successful when the lumen was reopened >80% and partially successful if >50%. even with repeated and prolonged applications.
There are, however, several shortcomings. Survival from the time of bronchoscopic treatment was also evaluated.
These include (1) a delayed mechanism of action -cytonecrosis is only complete about eight days after surgery so it is not indicated in the treatment of an emergency such as critical Results  1 tracheal obstruction; and (2) because the tissue response to cryosurgery is proportional to the Debulking was successful in 30 patients (60%), partially successful in 16 (32%), and un-tissue water and cell content, it is not indicated in the treatment of some benign neoplasms or successful in four (8%); 24 patients (16 with bronchial cancer and eight with tracheal can-those of fibrous tissues. For these reasons, in 1992 we tested several contact and non-contact cer) received a Dumon stent. Median survival was five months from surgery (range 0-14).
lasers and found that the high level of cutting precision produced by laser systems in other branches of surgery was not required in bronchology where effective coagulation is the main  2 Debulking was successful in 32 patients (66%), requirement. Moreover, the costs and hazards of lasers -including those for the staff -do not partially successful in 10 (21.5%), and unsuccessful in six (12.5%); 16 patients (10 with seem justified for a simple mechanical task such as tracheobronchial debulking. bronchial cancer and six with tracheal cancer) received a Dumon stent. Radiotherapy was Radiofrequency treatment has several advantages. It provides more precision in the performed in 42 patients (87.5%) within two weeks of cryotherapy at a mean dose of 50 Gy control of heat emission to the healthy surrounding tissues than traditional electro-(range 30-60) and six (12.5%) received six cycles of chemotherapy (cyclophosphamide cautery, and energy absorption is not dependent on the tissue colour (clear tissues 100 mg/m 2 +etoposide 80 mg/m 2 ), two for small cell lung cancer (SCLC) and four for refract laser light). The hazard of bronchial wall perforation is thus reduced. Furthermore, NSCLC. Twenty eight died from disease progression with no local recurrence at the radio-radiofrequency does not produce retracting scars on bronchoscopic follow up in cases of graphic and bronchoscopic follow up. The median survival time was 14 months (range benign neoplasms. Our experience therefore suggests that radiosurgery is effective in op-2-18). At March 1996 20 patients were still alive with no local recurrence, four of whom erative bronchoscopy.
Moreover, cryotherapy seems to enhance the (two with NSCLC treated with radiotherapy and two with NSCLC treated with chemo-responsiveness of bronchogenic tumours to radiotherapy and chemotherapy 15 16 by intherapy) were disease free after >24 months of follow up. The bronchoscopic appearance of a creasing the mitotic index and the neovascularisation of the tumour. The costs of patient before and after treatment with radiosurgery and cryotherapy is shown in fig 3. purchasing and maintaining the instruments for radiofrequency ablation and cryosurgery are No major complications related to the intervention or anaesthesia were observed. Only much lower than those of lasers (about £6000 for cryosurgery and £5000 for the radiominor complications occurred in two patients. In one case in group 1 the stent was obstructed frequency generator and bronchoscopic tools 
